Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug ...
An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...
Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.
Credit: Shutterstock. Adlarity is a once-weekly transdermal formulation of donepezil that is designed to be worn for 7 days with consistent adhesion. The Food and Drug Administration (FDA) has ...
"US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: Download Report: https://www.kuickresearch.com/report-us-transdermal ...
A bio-inspired dual-amplified patch (MN@EV/SC) was fabricated by integrating extracellular vesicle-loaded microneedles with a soft suction chamber for effective transdermal delivery. The MN@EV/SC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results